Bruker Corporation
BRKR
$39.13
-$0.68-1.71%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 977.20M | 860.50M | 797.40M | 801.40M | 979.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 977.20M | 860.50M | 797.40M | 801.40M | 979.60M |
| Cost of Revenue | 510.40M | 446.30M | 432.30M | 405.30M | 481.00M |
| Gross Profit | 466.80M | 414.20M | 365.10M | 396.10M | 498.60M |
| SG&A Expenses | 244.20M | 242.50M | 231.40M | 226.00M | 246.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 58.70M | -38.10M | 4.70M | 3.90M | 400.00K |
| Total Operating Expenses | 912.90M | 749.00M | 768.60M | 732.30M | 831.80M |
| Operating Income | 64.30M | 111.50M | 28.80M | 69.10M | 147.80M |
| Income Before Tax | 67.00M | -72.60M | 1.10M | 25.50M | 54.60M |
| Income Tax Expenses | 37.80M | -14.10M | -3.10M | 8.70M | 40.70M |
| Earnings from Continuing Operations | 29.20M | -58.50M | 4.20M | 16.80M | 13.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.20M | -1.10M | 3.40M | 600.00K | -200.00K |
| Net Income | 26.00M | -59.60M | 7.60M | 17.40M | 13.70M |
| EBIT | 64.30M | 111.50M | 28.80M | 69.10M | 147.80M |
| EBITDA | 122.40M | 167.20M | 84.90M | 119.50M | 200.70M |
| EPS Basic | 0.10 | -0.41 | 0.05 | 0.11 | 0.09 |
| Normalized Basic EPS | 0.20 | 0.43 | 0.10 | 0.27 | 0.56 |
| EPS Diluted | 0.10 | -0.41 | 0.05 | 0.11 | 0.09 |
| Normalized Diluted EPS | 0.20 | 0.43 | 0.10 | 0.27 | 0.56 |
| Average Basic Shares Outstanding | 152.00M | 151.80M | 151.60M | 151.60M | 151.60M |
| Average Diluted Shares Outstanding | 152.50M | 151.80M | 151.70M | 151.90M | 152.00M |
| Dividend Per Share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Payout Ratio | 67.69% | 0.00% | 100.00% | 44.25% | 55.47% |